Osteopontin inhibits osmotic swelling of retinal glial (Müller) cells by inducing release of VEGF

Neuroscience

Volumn 246, Issue , 2013, Pages 59-72

  Wahl, V ^a   Vogler, S ^a   Grosche, A ^a   Pannicke, T ^a   Ueffing, M ^b,c   Wiedemann, P ^a   Reichenbach, A ^a   Hauck, S M ^b   Bringmann, A ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Glia; Ischemia; Osmotic swelling; Osteopontin; Retina; VEGF

Indexed keywords

5 NITRO 2 (3 PHENYLPROPYLAMINO)BENZOIC ACID; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE TRIPHOSPHATE; BARIUM ION; CALCIUM; CALCIUM CHANNEL T TYPE; CHLORIDE CHANNEL; CLOFILIUM; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMIC ACID; HYDROGEN PEROXIDE; METABOTROPIC RECEPTOR; NEUTRALIZING ANTIBODY; OSTEOPONTIN; PHOSPHOLIPASE C; POTASSIUM CHANNEL; PROTEIN KINASE C; PURINERGIC P2Y RECEPTOR; TETRODOTOXIN; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 2; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL SWELLING; CONTROLLED STUDY; ENZYME ACTIVATION; EXOCYTOSIS; IMMUNOREACTIVITY; MUELLER CELL; NERVE CELL STIMULATION; NEUROPROTECTION; NONHUMAN; OSMOSIS; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RAT; RETINA BIPOLAR GANGLION CELL; RETINA ISCHEMIA;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPENDYMOGLIAL CELLS; NEUROGLIA; ORGAN CULTURE TECHNIQUES; OSMOSIS; OSMOTIC PRESSURE; OSTEOPONTIN; RATS; RATS, LONG-EVANS; RETINA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84878363370     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.04.045     Document Type: Article

References (63)

1. Birke M.T., Neumann C., Birke K., Kremers J., Scholz M. Changes of osteopontin in the aqueous humor of the DBA2/J glaucoma model correlated with optic nerve and RGC degenerations. Invest Ophthalmol Vis Sci 2010, 51:5759-5767.
2. Bowman E.J., Siebers A., Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A 1988, 85:7972-7976.
3. Bresnick G.H. Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology 1983, 90:1301-1317.
4. Bringmann A., Reichenbach A., Wiedemann P. Pathomechanisms of cystoid macular edema. Ophthalmic Res 2004, 36:241-249.
5. Bringmann A., Uckermann O., Pannicke T., Iandiev I., Reichenbach A., Wiedemann P. Neuronal versus glial cell swelling in the ischaemic retina. Acta Ophthalmol Scand 2005, 83:528-538.
6. Bringmann A., Pannicke T., Grosche J., Francke M., Wiedemann P., Skatchkov S.N., Osborne N.N., Reichenbach A. Müller cells in the healthy and diseased retina. Prog Retin Eye Res 2006, 25:397-424.
7. Bringmann A., Iandiev I., Pannicke T., Wurm A., Hollborn M., Wiedemann P., Osborne N.N., Reichenbach A. Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects. Prog Retin Eye Res 2009, 28:423-451.
8. Chaitin M.H., Brun-Zinkernagel A.M. Immunolocalization of CD44 in the dystrophic rat retina. Exp Eye Res 1998, 67:283-292.
9. Chaitin M.H., Wortham H.S., Brun-Zinkernagel A.M. Immunocytochemical localization of CD44 in the mouse retina. Exp Eye Res 1994, 58:359-366.
10. Chaitin M.H., Ankrum M.T., Wortham H.S. Distribution of CD44 in the retina during development and the rds degeneration. Dev Brain Res 1996, 94:92-98.
11. Chidlow G., Wood J.P., Manavis J., Osborne N.N., Casson R.J. Expression of osteopontin in the rat retina: effects of excitotoxic and ischemic injuries. Invest Ophthalmol Vis Sci 2008, 49:762-771.
12. Deeg C.A., Eberhardt C., Hofmaier F., Amann B., Hauck S.M. Osteopontin and fibronectin levels are decreased in vitreous of autoimmune uveitis and retinal expression of both proteins indicates ECM re-modeling. PLoS One 2011, 6:e27674.
13. rd1 mouse model of retinal degeneration. Glia 2011, 59:821-832.
14. Dietzel I., Heinemann U., Lux H.D. Relations between slow extracellular potential changes, glial potassium buffering, and electrolyte and cellular volume changes during neuronal hyperactivity in cat brain. Glia 1989, 2:25-44.
15. Dmitriev A.V., Govardovskii V.I., Schwahn H.N., Steinberg R.H. Light-induced changes of extracellular ions and volume in the isolated chick retina-pigment epithelium preparation. Vis Neurosci 1999, 16:1157-1167.
16. Dudek F.E., Obenhaus A., Tasker J.G. Osmolality-induced changes in extracellular volume alter epileptiform bursts independent of chemical synapses in the rat: importance of non-synaptic mechanisms in hippocampal epileptogenesis. Neurosci Lett 1990, 120:267-270.
17. Garcia M., Vecino E. Role of Müller glia in neuroprotection and regeneration in the retina. Histol Histopathol 2003, 18:1205-1218.
18. Ghiardi G.J., Gidday J.M., Roth S. The purine nucleoside adenosine in retinal ischemia-reperfusion injury. Vis Res 1999, 39:2519-2535.
19. Giachelli C.M., Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol 2000, 19:615-622.
20. Grimm C., Wenzel A., Groszer M., Mayser H., Seeliger M., Samardzija M., Bauer C., Gassmann M., Remé C.E. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 2002, 8:718-724.
21. Guo H., Cai C.Q., Schroeder R.A., Kuo P.C. Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages. J Immunol 2001, 166:1079-1086.
22. Harada T., Harada C., Nakayama N., Okuyama S., Yoshida K., Kohsaka S., Matsuda H., Wada K. Modification of glial-neuronal cell interactions prevents photoreceptor apoptosis during light-induced retinal degeneration. Neuron 2000, 26:533-541.
23. Harada C., Harada T., Quah H.M., Maekawa F., Yoshida K., Ohno S., Wada K., Parada L.F., Tanaka K. Potential role of glial cell line-derived neurotrophic factor receptors in Müller glial cells during light-induced retinal degeneration. Neuroscience 2003, 122:229-235.
24. Hauck S.M., Kinkl N., Deeg C.A., Swiatek-de Lange M., Schöffmann S., Ueffing M. GDNF family ligands trigger indirect neuroprotective signaling in retinal glial cells. Mol Cell Biol 2006, 26:2746-2757.
25. Hikita S.T., Vistica B.P., Jones H.R., Keswani J.R., Watson M.M., Ericson V.R., Ayoub G.S., Gery I., Clegg D.O. Osteopontin is proinflammatory in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 2006, 47:4435-4443.
26. Hirrlinger P.G., Wurm A., Hirrlinger J., Bringmann A., Reichenbach A. Osmotic swelling characteristics of glial cells in the murine hippocampus, cerebellum, and retina in situ. J Neurochem 2008, 105:1405-1417.
27. Housley G.D., Bringmann A., Reichenbach A. Purinergic signaling in special senses. Trends Neurosci 2009, 32:128-141.
28. Ju W.K., Kim K.Y., Cha J.H., Kim I.B., Lee M.Y., Oh S.J., Chung J.W., Chun M.H. Ganglion cells of the rat retina show osteopontin-like immunoreactivity. Brain Res 2000, 852:217-220.
29. Karl A., Wurm A., Pannicke T., Krügel K., Obara-Michlewska M., Wiedemann P., Reichenbach A., Albrecht J., Bringmann A. Synergistic action of hypoosmolarity and glutamine in inducing acute swelling of retinal glial (Müller) cells. Glia 2011, 59:256-266.
30. Koeberle P.D., Bähr M. The upregulation of GLAST-1 is an indirect antiapoptotic mechanism of GDNF and neurturin in the adult CNS. Cell Death Differ 2008, 15:471-483.
31. Kofuji P., Biedermann B., Siddharthan V., Raap M., Iandiev I., Milenkovic I., Thomzig A., Veh R.W., Bringmann A., Reichenbach A. Kir potassium channel subunit expression in retinal glial cells: implications for spatial potassium buffering. Glia 2002, 39:292-303.
32. Krishnamoorthy R., Agarwal N., Chaitin M.H. Upregulation of CD44 expression in the retina during the rds degeneration. Mol Brain Res 2000, 77:125-130.
33. Krügel K., Wurm A., Linnertz R., Pannicke T., Wiedemann P., Reichenbach A., Bringmann A. Erythropoietin inhibits osmotic swelling of retinal glial cells by Janus kinase and extracellular signal-regulated kinases1/2-mediated release of vascular endothelial growth factor. Neuroscience 2010, 165:1147-1158.
34. Krügel K., Wurm A., Pannicke T., Hollborn M., Karl A., Wiedemann P., Reichenbach A., Kohen L., Bringmann A. Involvement of oxidative stress and mitochondrial dysfunction in the osmotic swelling of retinal glial cells from diabetic rats. Exp Eye Res 2011, 92:87-93.
35. Kuhrt H., Härtig W., Grimm D., Faude F., Kasper M., Reichenbach A. Changes in CD44 and ApoE immunoreactivities due to retinal pathology of man and rat. J Hirnforsch 1997, 38:223-229.
36. Larsen A.K., Osborne N.N. Involvement of adenosine in retinal ischemia. Studies on the rat. Invest Ophthalmol Vis Sci 1996, 37:2603-2611.
37. 2+ channels is required for vesicular release of glutamate from retinal glial cells implicated in cell volume regulation. Neuroscience 2011, 188:23-34.
38. Neufeld A.H., Kawai S., Das S., Vora S., Gachie E., Connor J.R., Manning P.T. Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase. Exp Eye Res 2002, 75:521-528.
39. Newman E.A. Glial cell inhibition of neurons by release of ATP. J Neurosci 2003, 23:1659-1666.
40. Newman E.A., Zahs K.R. Modulation of neuronal activity by glial cells in the retina. J Neurosci 1998, 18:4022-4028.
41. Ostwald P., Park S.S., Toledano A.Y., Roth S. Adenosine receptor blockade and nitric oxide synthase inhibition in the retina: impact upon post-ischemic hyperemia and the electroretinogram. Vis Res 1997, 37:3453-3461.
42. Pannicke T., Iandiev I., Uckermann O., Biedermann B., Kutzera F., Wiedemann P., Wolburg H., Reichenbach A., Bringmann A. A potassium channel-linked mechanism of glial cell swelling in the postischemic retina. Mol Cell Neurosci 2004, 26:493-502.
43. Rollo E.E., Laskin D.L., Denhardt D.T. Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages. J Leukoc Biol 1996, 60:397-404.
44. Rothova A., Suttorp-van Schulten M.S., Frits Treffers W., Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996, 80:332-336.
45. Shinoe T., Kuribayashi H., Saya H., Seiki M., Aburatani H., Watanabe S. Identification of CD44 as a cell surface marker for Müller glia precursor cells. J Neurochem 2010, 115:1633-1642.
46. Skatchkov S.N., Eaton M.J., Shuba Y.M., Kucheryavykh Y.V., Derst C., Veh R.W., Wurm A., Iandiev I., Pannicke T., Bringmann A., Reichenbach A. Tandem-pore domain potassium channels are functionally expressed in retinal (Müller) glial cells. Glia 2006, 53:266-276.
47. Slezak M., Grosche A., Niemiec A., Tanimoto N., Pannicke T., Münch T.A., Crocker B., Isope P., Härtig W., Beck S.C., Huber G., Ferracci G., Perraut M., Reber M., Miehe M., Demais V., Lévêque C., Metzger D., Szklarczyk K., Przewlocki R., Seeliger M.W., Sage-Ciocca D., Hirrlinger J., Reichenbach A., Reibel S., Pfrieger F.W. Relevance of exocytotic glutamate release from retinal glia. Neuron 2012, 74:504-516.
48. Storkebaum E., Lambrechts D., Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 2004, 26:943-954.
49. Suzuki H., Hasegawa Y., Ayer R., Sugawara T., Chen W., Sozen T., Kanamaru K., Taki W., Zhang J.H. Effects of recombinant osteopontin on blood-brain barrier disruption after subarachnoid hemorrhage in rats. Acta Neurochir Suppl 2011, 111:231-236.
50. Tian J.Y., Sørensen E.S., Butler W.T., Lopez C.A., Sy M.S., Desai N.K., Denhardt D.T. Regulation of no synthesis induced by inflammatory mediators in RAW264.7 cells: collagen prevents inhibition by osteopontin. Cytokine 2000, 12:450-457.
51. Uckermann O., Vargová L., Ulbricht E., Klaus C., Weick M., Rillich K., Wiedemann P., Reichenbach A., Syková E., Bringmann A. Glutamate-evoked alterations of glial and neuronal cell morphology in the guinea-pig retina. J Neurosci 2004, 24:10149-10158.
52. Uckermann O., Kutzera F., Wolf A., Pannicke T., Reichenbach A., Wiedemann P., Wolf S., Bringmann A. The glucocorticoid triamcinolone acetonide inhibits osmotic swelling of retinal glial cells via stimulation of endogenous adenosine signaling. J Pharmacol Exp Ther 2005, 315:1036-1045.
53. Uckermann O., Wolf A., Kutzera F., Kalisch F., Beck-Sickinger A., Wiedemann P., Reichenbach A., Bringmann A. Glutamate release by neurons evokes a purinergic inhibitory mechanism of osmotic glial cell swelling in the rat retina: activation by neuropeptide Y. J Neurosci Res 2006, 83:538-550.
54. Wahlin K.J., Campochiaro P.A., Zack D.J., Adler R. Neurotrophic factors cause activation of intracellular signaling pathways in Müller cells and other cells of the inner retina, but not photoreceptors. Invest Ophthalmol Vis Sci 2000, 41:927-936.
55. 3/PI3K/Akt/eNOS/NO signaling pathway in glioma cells. Eur J Cell Biol 2011, 90:642-648.
56. Weber G.F., Ashkar S., Glimcher M.J., Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996, 271:509-512.
57. Wen R., Song Y., Cheng T., Matthes M.T., Yasumura D., LaVail M.M., Steinberg R.H. Injury-induced upregulation of bFGF and CNTF mRNAs in the rat retina. J Neurosci 1995, 15:7377-7385.
58. Wexler E.M., Berkovich O., Nawy S. Role of the low-affinity NGF receptor (p75) in survival of retinal bipolar cells. Vis Neurosci 1998, 15:211-218.
59. Wurm A., Pannicke T., Wiedemann P., Reichenbach A., Bringmann A. Glial cell-derived glutamate mediates autocrine cell volume regulation in the retina: activation by VEGF. J Neurochem 2008, 104:386-399.
60. 1 adenosine receptors in osmotic volume regulation of retinal glial cells in mice. Mol Vis 2009, 15:1858-1867.
61. Wurm A., Lipp S., Pannicke T., Linnertz R., Krügel U., Schulz A., Färber K., Zahn D., Grosse J., Wiedemann P., Chen J., Schöneberg T., Illes P., Reichenbach A., Bringmann A. Endogenous purinergic signaling is required for osmotic volume regulation of retinal glial cells. J Neurochem 2010, 112:1261-1272.
62. Xie Y., Sakatsume M., Nishi S., Narita I., Arakawa M., Gejyo F. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 2001, 60:1645-1657.
63. Yasuhara T., Shingo T., Date I. The potential role of vascular endothelial growth factor in the central nervous system. Rev Neurosci 2004, 15:293-307.